NOTCH-YAP1/TEAD-DNMT1 Axis Drives Hepatocyte Reprogramming Into Intrahepatic Cholangiocarcinoma-Reference-Cited by-同舟云学术

NOTCH-YAP1/TEAD-DNMT1 Axis Drives Hepatocyte Reprogramming Into Intrahepatic Cholangiocarcinoma

Published:2022-08 Issue:2 Volume:163 Page:449-465
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Hu Shikai,Molina Laura,Tao Junyan,Liu Silvia,Hassan Mohammed,Singh Sucha,Poddar Minakshi,Bell Aaron,Sia Daniela,Oertel Michael,Raeman Reben,Nejak-Bowen Kari,Singhi Aatur,Luo Jianhua,Monga Satdarshan P.^ORCID,Ko Sungjin

Funder

Pittsburgh Liver Research Center, University of Pittsburgh

National Institutes of Health

National Cancer Institute

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference63 articles.

1. Cancer Stat Facts: Liver and Intrahepatic Bile Duct Cancer,2018

2. Molecular pathways and targeted therapy in cholangiocarcinoma;Dabney;Clin Adv Hematol Oncol,2019

3. Molecular targeted therapies: ready for “prime time” in biliary tract cancer;Lamarca;J Hepatol,2020

4. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA);Banales;Nat Rev Gastroenterol Hepatol,2016

5. The current management of cholangiocarcinoma: a comparison of current guidelines;Cai;Biosci Trends,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of PRMT5 as a therapeutic target in cholangiocarcinoma;Gut;2024-09-11

2. Epigenetic regulation in liver regeneration;Life Sciences;2024-09

3. Context-Dependent Distinct Roles of SOX9 in Combined Hepatocellular Carcinoma–Cholangiocarcinoma;Cells;2024-08-29

4. The diagnostic value of a nomogram based on enhanced CT radiomics for differentiating between intrahepatic cholangiocarcinoma and early hepatic abscess;Frontiers in Molecular Biosciences;2024-08-23

5. Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy;Molecular Carcinogenesis;2024-08-02